Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,000 | 61,000 | -129,000 | -65,000 | 118,000 |
| Depreciation Amortization | 11,000 | 5,000 | 15,000 | 19,000 | 12,000 |
| Income taxes - deferred | -24,000 | 3,000 | -65,000 | N/A | N/A |
| Accounts receivable | -6,000 | 4,000 | -33,000 | -26,000 | -8,000 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 91,000 | 60,000 |
| Other Working Capital | 78,000 | -113,000 | -294,000 | 61,000 | -147,000 |
| Other Operating Activity | 28,000 | 3,000 | 206,000 | -114,000 | -90,000 |
| Operating Cash Flow | $51,000 | $-37,000 | $-300,000 | $-34,000 | $-55,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,000 | -4,000 | -45,000 | -40,000 | -36,000 |
| PPE Investments | -6,000 | -2,000 | -8,000 | -128,000 | -126,000 |
| Net Acquisitions | N/A | N/A | -129,000 | N/A | N/A |
| Sale Of Investment | 42,000 | 31,000 | 129,000 | 95,000 | 64,000 |
| Purchase Sale Intangibles | -1,000 | -1,000 | -45,000 | -31,000 | -5,000 |
| Other Investing Activity | -1,000 | 0 | -42,000 | -31,000 | -5,000 |
| Investing Cash Flow | $26,000 | $25,000 | $-95,000 | $-104,000 | $-103,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,000 | -1,000 | -12,000 | -12,000 | -11,000 |
| Common Stock Issued | 2,000 | 2,000 | 3,000 | 4,000 | 2,000 |
| Common Stock Repurchased | -71,000 | -36,000 | -33,000 | -11,000 | -11,000 |
| Other Financing Activity | -21,000 | -21,000 | -22,000 | -6,000 | -4,000 |
| Financing Cash Flow | $-91,000 | $-56,000 | $-64,000 | $-25,000 | $-24,000 |
| Exchange Rate Effect | N/A | N/A | 1,000 | -1,000 | N/A |
| Beginning Cash Position | 316,000 | 316,000 | 774,000 | 774,000 | 774,000 |
| End Cash Position | 302,000 | 248,000 | 316,000 | 610,000 | 592,000 |
| Net Cash Flow | $-14,000 | $-68,000 | $-458,000 | $-164,000 | $-182,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 51,000 | -37,000 | -300,000 | -34,000 | -55,000 |
| Capital Expenditure | -6,000 | -2,000 | -8,000 | -128,000 | -126,000 |
| Free Cash Flow | 45,000 | -39,000 | -308,000 | -162,000 | -181,000 |